<DOC>
	<DOCNO>NCT02863757</DOCNO>
	<brief_summary>The purpose study determine disease progression CHB/NAFLD compare CHB NAFLD include liver cirrhosis , cirrhotic complication hepatocellular carcinoma ( HCC ) .</brief_summary>
	<brief_title>Follow-up Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver Disease</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Hepatitis B , Chronic</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<criteria>Liver biopsy prove CHB and/or NAFLD baseline ; Chinese Followup duration &gt; 12 month Other liver disease ; Secondary cause hepatic steatosis ; Alcohol abuse ; Liver cirrhosis , cirrhosis related complication HCC baseline ; Malignancy ; History liver transplantation</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>